OM
INFI

Opaleye Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Opaleye Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,171,800
Closed -$6.72M – 67
2020
Q4 		$6.72M Hold
3,171,800
– – 0.88% 32
2020
Q3 		$137K Buy
+3,171,800
New +$3.26M 0.03% 53
2018
Q4 		– Sell
-275,000
Closed -$745K – 56
2018
Q3 		$745K Buy
+275,000
New +$569K 0.19% 45
2014
Q1 		– Sell
-130,000
Closed -$1.67M – 32
2013
Q4 		$1.67M Buy
+130,000
New +$1.84M 1.31% 20

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
TLP
Tri Locum Partners New York $713M AUM 68.92% 1-Year Est. Return
GPC
Guardian Point Capital Charlottesville, Virginia $243M AUM 22.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Opaleye Management's INFI Position: Q1 2021 in Review

Opaleye Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2021, closing a stake of 3,171,800 shares — an estimated $6.72M sold.

Opaleye Management first reported a position in INFI in Q4 2013 and held it in 4 quarters. The position peaked at $6.72M in Q4 2020. 83 funds tracked by Wall St. Rank hold INFI as of Q1 2021.

  • Opaleye Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • Opaleye Management sold 3,171,800 Infinity Pharmaceuticals, Inc. shares in Q1 2021, an estimated $6.72M.
  • Opaleye Management first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2013 and held it in 4 quarters.
  • Opaleye Management's Infinity Pharmaceuticals, Inc. position peaked at $6.72M in Q4 2020.
  • 83 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2021.

Based on Opaleye Management's 13F filing for Q1 2021, filed 18 May 2021.